Outstanding AI Tools For Neuro Conditions

A Comprehensive Suite of AI Solutions for Neurovascular Conditions

“Time is brain” is a well-known adage, particularly for patients with head trauma and stroke, where every minute counts. Avicenna.AI provides efficient solutions not only for the detection of traumatic brain injury (TBI) and hemorrhagic stroke, but also for the identification and quantification of acute ischemic stroke. Our triage tools enable fast detection to improve clinical workflow. We address data overload and fatigue to reduce errors and misdiagnosis.

INTRACRANIAL HEMORRHAGE

Intracranial hemorrhages (ICH) impact over two million individuals worldwide, with a high patient mortality rate of 40-50% within one month and 80% disability despite aggressive care.

Early and precise diagnosis of ICH is crucial for prompt therapeutic responses and improved outcomes.

CINA-ICH is able to detect suspected intracranial hemorrhage on Non-Contrast CT Scan, significantly reducing turnaround time for head trauma injuries, and hemorrhagic stroke patients.

CINA-ICH is capable of identifying five categories of intracranial hemorrhages, which encompass: IPH – Intraparenchymal, IVH – Intraventricular, SAH – Subarachnoid, SDH – Subdural, and EDH – Epidural.

Learn more about the validation of our CINA-ICH solution.

AI as Your Second Set of Eyes in Hemorrhage Detection

Imagine a tool designed to act as a second set of eyes for healthcare professionals, enhancing confidence and precision in diagnosing intracranial hemorrhages. This CINA-ICH case study illustrates how advanced AI-driven detection can assist radiologists in identifying critical findings swiftly, supporting faster decisions and improved patient outcomes in time-sensitive situations.

Time For Triage

0 "

Sensitivity

0 %

Specificity

0 %

Accuracy

0 %

LARGE VESSEL OCCLUSION

There are two types of acute ischemic strokes: small vessel occlusion (SVO) and large vessel occlusion (LVO).

Approximately 80% of all strokes are caused by Ischemic stroke due to a Large Vessel Occlusion (LVO).

Early diagnosis of LVO is crucial as every 10 minutes of delay can significantly impact the patient’s disability outcome.

CINA-LVO swiftly detects LVO in the anterior circulation (distal ICA, M1, or proximal M2) on head CT angiographies and prioritizes these cases in the radiologist’s worklist.

Learn more about the validation of our CINA-LVO solution.

Enhancing Stroke Diagnosis : A Second Opinion That Saves Time

Discover how CINA-LVO helps healthcare professionals make timely, accurate decisions in critical moments. Download the case study ‘TIME IS BRAIN – The Importance of a Second Opinion’ to explore the impact of AI in enhancing diagnostic confidence and improving patient outcomes.

Time For Triage

0 "

Sensitivity

0 %

Specificity

0 %

Accuracy

0 %

ASPECT SCORE

The ASPECTS (Alberta Stroke Program Early CT Score) is a scoring system used in radiology to assess early signs of ischemic stroke on a computed tomography (CT) scan of the brain. CINA-ASPECTS, an AI-based quantification tool, facilitates faster, more consistent, and precise assessment of acute ischemic stroke.

Besides the ASPECT Score, CINA-ASPECTS offers:

A heat map indicating the probability of hypodensity and/or sulcal effacement,
Outlines infarcted regions,

This standardized approach enhances the evaluation of ischemic stroke cases eligible for mechanical thrombectomy and/or intravenous thrombolysis (IVT).

Learn more about the validation of our CINA-ASPECTS solution.

Sensitivity

0 %

Specificity

0 %

Accuracy

0 %

CINA and CINA-ASPECTS, medical images analysis softwares, are medical devices manufactured by Avicenna.AI. These medical devices are reserved for health professionals.

These software have been designed and manufactured according to the EN ISO 13485 Quality management system. Read the instructions in the notice carefully before any use.

Instructions for Use are available here.
Manufacturer: Avicenna.AI (France).
Medical devices Class IIb following the European Regulation on Medical Device (EU) 2017/745 (CE 2797). Medical devices Class II following the Code of Federal Regulations of the United States of America 21CFR on Medical Devices.

A Comprehensive Suite of AI Solutions for Neurovascular Conditions

INTRACRANIAL HEMORRHAGE

AI as Your Second Set of Eyes in Hemorrhage Detection

LARGE VESSEL OCCLUSION

Enhancing Stroke Diagnosis : A Second Opinion That Saves Time

ASPECT SCORE

COMPLIANCE

MY AVICENNA PLATFORM

Newsletter